Kronos Worldwide (NYSE:KRO) Trading 5.3% Higher

Share on StockTwits

Kronos Worldwide, Inc. (NYSE:KRO) shares traded up 5.3% during trading on Friday . The company traded as high as $15.09 and last traded at $14.51, 504,877 shares traded hands during mid-day trading. An increase of 77% from the average session volume of 285,524 shares. The stock had previously closed at $13.78.

A number of research analysts recently commented on the company. ValuEngine upgraded Kronos Worldwide from a “sell” rating to a “hold” rating in a report on Tuesday, September 10th. SunTrust Banks decreased their price objective on Kronos Worldwide from $13.00 to $12.00 and set a “hold” rating on the stock in a report on Friday, October 11th.

The stock has a market capitalization of $1.59 billion, a price-to-earnings ratio of 8.20 and a beta of 2.04. The business has a fifty day moving average of $12.30 and a 200 day moving average of $12.85. The company has a debt-to-equity ratio of 0.61, a current ratio of 4.94 and a quick ratio of 2.98.

Kronos Worldwide (NYSE:KRO) last released its quarterly earnings data on Thursday, November 7th. The specialty chemicals company reported $0.16 EPS for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.02). Kronos Worldwide had a net margin of 6.93% and a return on equity of 13.56%. The business had revenue of $437.40 million during the quarter, compared to analyst estimates of $427.54 million. During the same quarter in the prior year, the company posted $0.28 earnings per share. The company’s revenue was up 6.6% on a year-over-year basis. On average, equities research analysts expect that Kronos Worldwide, Inc. will post 0.83 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 12th. Investors of record on Tuesday, December 3rd will be issued a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a yield of 4.96%. The ex-dividend date of this dividend is Monday, December 2nd. Kronos Worldwide’s dividend payout ratio is presently 40.68%.

A number of large investors have recently added to or reduced their stakes in the business. BlackRock Inc. lifted its stake in Kronos Worldwide by 7.2% during the second quarter. BlackRock Inc. now owns 2,333,819 shares of the specialty chemicals company’s stock worth $35,754,000 after purchasing an additional 156,220 shares in the last quarter. Bank of New York Mellon Corp lifted its stake in Kronos Worldwide by 4.5% during the second quarter. Bank of New York Mellon Corp now owns 1,757,888 shares of the specialty chemicals company’s stock worth $26,931,000 after purchasing an additional 75,326 shares in the last quarter. Parametric Portfolio Associates LLC lifted its stake in Kronos Worldwide by 18.7% during the second quarter. Parametric Portfolio Associates LLC now owns 560,693 shares of the specialty chemicals company’s stock worth $8,590,000 after purchasing an additional 88,416 shares in the last quarter. Kempen Capital Management N.V. lifted its stake in Kronos Worldwide by 20.4% during the second quarter. Kempen Capital Management N.V. now owns 442,000 shares of the specialty chemicals company’s stock worth $6,771,000 after purchasing an additional 75,000 shares in the last quarter. Finally, Amundi Pioneer Asset Management Inc. acquired a new position in Kronos Worldwide during the first quarter worth $5,536,000. Institutional investors own 19.66% of the company’s stock.

Kronos Worldwide Company Profile (NYSE:KRO)

Kronos Worldwide, Inc produces and markets titanium dioxide pigments (TiO2) in Europe, North America, the Asia Pacific, and internationally. It produces TiO2 in two crystalline forms, rutile and anatase to impart whiteness, brightness, opacity, and durability for various products, including paints, coatings, plastics, paper, fibers, and ceramics, as well as for various specialty products, such as inks, foods, and cosmetics.

See Also: Trading on Margin

Receive News & Ratings for Kronos Worldwide Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kronos Worldwide and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.